Clinical research involving cannabis has had a challenging history; until very recently (and arguably still) it remains an area of clinical research characterized by historically heavy regulation and seemingly endless […] Read More >>
As cannabis legalization is celebrated across Canada, healthcare practitioners will have to be more informed than ever regarding the implications of cannabis use. With some consumers looking to try recreational cannabis […] Read More >>
Every day, we take for granted the medical treatments offered by our physicians for illnesses like hypertension and epilepsy. If medical professionals and the pharmaceutical industry did not invest in […] Read More >>
dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.
Stay abreast of regulatory updates, news, events, offers and more
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.